Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 7/20 | 0.46 |
| ▸ | PPARG | P37231 | 5/20 | 0.46 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | CETP | P11597 | 1/20 | 0.36 |
| ▸ | LPL | P06858 | 1/20 | 0.36 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24117321 | 1.00 | PPARA (0.46) | PPARAPPARGSPHK2SPHK1CNR1 | |
| SCHEMBL24117328 | 0.93 | PPARA (0.43) | PPARAPPARGSPHK2SPHK1CNR1 | |
| SCHEMBL24117329 | 0.91 | ENPP2 (0.39) | PPARAPPARGSPHK2SPHK1CNR1 | |
| SCHEMBL24117325 | 0.87 | ENPP2 (0.35) | PPARAPPARGSPHK2SPHK1CNR1 | |
| SCHEMBL24117322 | 0.87 | ENPP2 (0.39) | PPARAPPARGSPHK2SPHK1CNR1 | |
| SCHEMBL24117324 | 0.83 | PPARG (0.32) | PPARAPPARGCNR1CNR2 | |
| SCHEMBL24117323 | 0.78 | MEN1 (0.32) | — | |
| SCHEMBL13400258 | 0.77 | PPARA (0.56) | PPARAPPARGCETPLPLLIPG | |
| SCHEMBL6429074 | 0.77 | PPARA (0.56) | PPARAPPARGCETPLPLLIPG | |
| SCHEMBL6429150 | 0.76 | PPARA (0.56) | PPARAPPARGLPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210395633-A1 | Organophosphorus compound, and preparation process and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2021-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395633-A1 | Organophosphorus compound, and preparation process and use thereof | FEN1, PON1, GK | PPARA 190/4885PPARG 28/4885SPHK2 2923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.